| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |